NCT01812200View on ClinicalTrials.gov

Antithrombotic Triple Therapy in Humans

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

July 31, 2013

Conditions
Atrial FibrillationAcute Coronary Syndrome
Interventions
DRUG

Dabigatran, Ticagrelor, ASA

DRUG

Rivaroxaban, Ticagrelor, ASA

DRUG

Phenprocoumon, Ticagrelor, ASA

Trial Locations (1)

1090

Medical University of Vienna; Department of Clinical Pharmacology, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT01812200 - Antithrombotic Triple Therapy in Humans | Biotech Hunter | Biotech Hunter